Our partners’ expertise includes advocacy and research promotion, managing country participation, innovative e-solutions, training programs and health expertise, and medicine donation.
Read more about:
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) of the International AIDS Society (IAS) is aimed at optimizing clinical management and delivery of services to infants, children and adolescents affected by HIV in resource-limited settings through advocacy and research promotion.
“We are proud to support New Horizons with increasing research capacity and advocacy for improved services for children and adolescents living with HIV.”
—Marissa Vicari, Manager, CIPHER
The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) is dedicated to preventing pediatric HIV infection and eliminating pediatric AIDS through research, advocacy, and prevention, care, and treatment programs. EGPAF manages the Expression of Interest application process, convenes the independent Review Committee for country selection and provides technical assistance for the countries participating in New Horizons.
“Collaborating with countries and building healthcare infrastructure is an essential part of New Horizon’s mission to improve HIV treatment for children and adolescents.”
—Natella Rakhmanina, Senior Technical Advisor, EGPAF
Imperial Health Sciences is a division of Imperial Logistics. Imperial is Africa’s largest logistics company, and the twentieth largest logistics company globally (Armstrong & Associates, 2013). As a leading influence in African healthcare supply chain management, Imperial Health Sciences has extensive experience across a variety of channels — distributors, wholesalers, private and public health sectors, doctors, pharmacies, hospitals and fast moving consumer health commodities. Specializing in multichannel solutions for delivering essential medicines and consumer health products in Africa (e.g. South Africa, Namibia, Botswana, Mozambique, Zambia, Kenya, Tanzania, Malawi, Uganda, Ethiopia, Rwanda, Zimbabwe, Ghana, Cote d’Ivoire and Nigeria) — Imperial is a trusted end-to-end supply chain service partner, offering clients the reliability and confidence that is key in the healthcare sector.
“We are proud to support the New Horizons Collaborative and provide effective solutions for supplying essentual medicines to children in need of treatment.”
—Dr. Iain Barton, Healthcare Strategy Executive, Imperial Logistics
The Partnership for Supply Chain Management’s (PFSCM) goals are to ensure reliable availability of essential products to programs in developing countries and to strengthen national supply chains to become sustainable mechanisms for delivering products to clients. PFSCM manages the donation of pediatric HIV medicines to eligible countries, providing a single conduit between Janssen and country treatment programs.
“We are proud to partner with the New Horizons Collaborative to support their donation program's efforts to improve access to pediatric HIV medicines. Through our procurement and distribution expertise, we are helping to ensure a reliable and secure supply chain to assist this important program in meeting their worthy goals.”
—Richard C. Owens, Jr., Director, PFSCM
The Relevance Network provides innovative e-solutions for the health and social development sectors, integration of analytics engines and capacity building for clinical and social science research initiatives.
“We work collaboratively with New Horizons stakeholders to improve HIV monitoring and support life saving research.”
—Craig Carty, CEO, The Relevance Network
The Right to Care Paediatric and Adolescent Department supports and delivers prevention, care, and treatment services for HIV and associated diseases. Right to Care provides advanced training programs in several African countries on the management of treatment-experienced patients and HIV drug resistance.
“I think it is amazing that not only does the New Horizons Collaborative supply these life-saving third line antiretroviral medications to recipient countries but they also make sure that the countries develop the relevant expertise to be able to use these medications.”
—Dr. Leon Levin, Head - Paediatric and Adolescent Programmes, Right to Care